Methods: 1091 patients with suspected ischemic chest pain underwent a clinically indicated angiography and enrolled in this study. Significant CAD was defined as !50% stenosis in any one major epicardial coronary artery. Multivariate logistic regression was used to determine predictors of significant CAD. Results: More women than men were found with normal/non-significant CAD (44.3% vs. 29.5%), but more men were shown either left-main or three-vessel disease (25.5% vs. 14.2%). Among patients with significant CAD, more women had relatively mild coronary artery lesions (50-74% stenosis) (27.5% vs. 16.5%), more men had the most severity CAD (90-100% stenosis) (65.3% vs. 56.5%). Risk factors independently associated with significant CAD including age, hypertension, diabetes mellitus, and prior myocardial infarction for both genders, LDL-C (>100 mg/dl) was separately for men, and postmenopause was separately for women. Conclusions: Women referred for angiography are more likely to have normal or nonsignificant CAD and lower rates of significant CAD compared with men across all ages. Predictors of significant CAD of Chinese population were similar with Western population. It was a fortunate result because measures of CAD primary prevention used in Western countries may be also suitable for China.
Objectives: Cardiac hybrid imaging helps improve the diagnostic accuracy of coronary artery disease (CAD) and provides important, comprehensive information necessary for timely and appropriate treatment. We aimed at assessing the potential value of cardiac hybrid imaging on the selection of appropriate management strategy for CAD. Methods: 238 patients underwent two day stress/rest 99m Tc-MIBI single-photo emission computed tomography (SPECT) and coronary computed tomography angiography (CCTA) on a separate scanner for CAD evaluation prior to treatment. Patients were divided into 3 groups according to the findings by hybrid SPECT and CCTA: (1) both CCTA and SPECT results were abnormal, meanwhile the stenoses found by CCTA and the ischemic myocardium found by SPECT matched well; (2) SPECT and CCTA findings did not match; and (3) both SPECT and CCTA results were normal. According to the hybrid imaging results, 4 types of treatment decisions were made listed as following: (1) no therapy; (2) optimal medical treatment (OMT); (3) percutaneous coronary intervention (PCI); and (4) coronary artery bypass grafting (CABG). Follow-up was performed during the first 60 days after hybrid imaging. Results: Hybrid images revealed matched, unmatched, and normal findings in 66, 106, and 66 patients. The Invasive Coronary Angiography (ICA) rate within 60 days was 64% (42/66), 9% (10/106) and 0% (0/66) for matched, unmatched and normal findings, respectively. And revascularization rate was 51.5% (34/66), 0% (0/106) and 0% (0/66) for matched, unmatched and normal findings, respectively. Conclusions: The incremental value of hybrid cardiac imaging resides in the accurate spatial co-localization of myocardial perfusion defects and subtending coronary arteries. So it may facilitate the identification of haemodynamically significant coronary artery stenoses and thereby guide clinicians on the appropriate treatment strategy for CAD.
GW25-e2200
Blood neopterin and endothelin levels in patients with coronary heart disease Zhu Zhijun, Wu Danning the 117th Hospital of PLA Objectives: To investigate the serum neopterin and endothelin levels in patients with coronary heart disease (CHD), to implore the probable mechanism of immune and endothelium function in CHD. Methods: The levels of neopterin and endothelin in 56 persons who were divided into two group, (control group, n¼16) and (patient group, n¼40) confirmed by coronary angiography, were measured. The relationship between the levels of neopterin, endothelin and the number of narrow artery in coronary heart disease patients was analyzed.
Results: The levels of neopterin in patients was higher than that in control group (respectively 15.16AE7.44 nmol/L and 8.38AE4.69 nmol/L, P<0.01). It got more higher with the number of diseased coronary artery in patients got more (r¼ 0.378 P< 0.05). The levels of endothelin in patients was higher than that in control group (respectively 93.41AE27.33 mg/L and 67.58AE20.04 mg/L, P<0.01). But it got not higher with the number of diseased coronary artery in patients got more (r¼ 0.298, P> 0.05). The levels of neopterin got much higher with the levels of endothelin increased. There was a positive relationship between neopterin and endothelin levels in the patients (r¼ 0.350, P <0.05). Conclusions: Neopterin and immune may take part in the pathophysiological process of CHD and they also affect the endothelium function.
GW25-e4543
The relationship of thyroid function and the severity of coronary artery in patients with coronary artery disease Xue Chao, Bian Ling Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Objectives: To evaluate thyroid function in hospitalized patients with coronary heart condition (CAD) and to explore and the relationship between free thyroxine (FT3) level and the severity of coronary artery stenosis in CAD patients. Methods: A total of 238 CAD patients who were admitted into our hospital during 2012 to 2014 were selected to perform serum thyroxine levels. The first purpose was to explore the thyroid function in patients with coronary heart disease. Then patients with hyperthyroidism, hypothyroidism, subclinical hyperthyroidism and subclinical hypothyroidism were excluded, the remaining patients were divided into normal FT3 group and low FT3 group according to FT3 levels. The second purpose was to compare the general clinical condition and the severity of coronary artery in the two groups of patients. Results: (1) Among 238 CAD patients, 2 cases with hyperthyroidism (0.84%), 11 cases with hypothyroidism (4.62%), 3 cases with subclinical hyperthyroidism (1.26%), 5 cases with subclinical hypothyroidism (2.10%), and 25 cases with low T3 syndrome (10.50%). Low T3 syndrome is most common thyroid dysfunction in patients with CAD. (2) Patients with low FT3 had higher level of total cholesterol (TC) and apolipoprotein E (ApoE) than normal FT3 group (P 0.005), meanwhile they also had higher level of creatinine (P¼0.007) and NT-proBNP (P<0.001) than normal FT3 group. (3) Low FT3 patients had higher proportion of three-vessel disease than normal FT3 group (P <0.001).
Conclusions:
The low T3 syndrome is most common thyroid dysfunction in patients with coronary heart disease, and patients with low FT3 are more likely to multi-vessel involvement.
GW25-e5211
The relationship between serum TNF-a and sICAM levels and the severity of coronary artery diseases Zhang Xingtong, Huang Dayang, Wang Miao, Zhao Juan First Affiliated hospital of Harbin Medical University Objectives: To identify the role of tumor necrosis factor-a (TNF-a) and soluble intercellular adhesion molecule (sICAM) in the process of coronary artery diseases and assess the correlation between TNF-a and sICAM levels and the severity of coronary artery diseases (CAD). Methods: The serum concentration of TNF-a and sICAM were measured in peripheral blood (venae radiales) of 30 patients with acute myocardial infarction (AMI),30 with stable angina pectoris (AP),and 30 control cases (Con) who were healthy subjects. For patients with AMI, the blood samples were obtained in 24 hours after acute myocardial infarction. For patients with AP, the blood samples were obtained in 24 hours after the latest angina pectoris. All the blood samples were obtained in the fasting state. The serum concentration of TNF-a and sICAM were measured by enzyme linked immunosorbent assay. The general data were recorded, such as gender, age, history of disease, and smoking. One-way ANOVA and Pearson correlation coefficient were used to analyze the results. Results: There was no significant difference in gender, age, history of disease, and smoking among the three groups (P>0.05).The TC, TG, LDL levels of AMI and AP groups were significantly higher than the Con group (P<0.05), but there was no significant difference between AMI and AP group (P>0.05). The serum concentrations of TNF-a and sICAM (ug/l) in patients with AMI were higher than the AP and the Con subjects (P<0.01).And the AP group was higher than the Con group (P<0.01). (TNF-a: AMI 0.46AE0.44, AP 0.076AE0.023, Con 0.059AE0.012, sICAM: AMI 1.37AE0.44, AP 0.75AE0.25, Con 0.47AE0.23) (P<0.01). In the three groups, the levels of TNF-a and sICAM were positively correlated (r¼0.634, P<0.01). Conclusions: TNF-a and sICAM were involved in the process of coronary artery diseases. They were positively correlated with the severity of CAD.
GW25-e5396
The Objectives: Macrophage migration inhibitory factor (MIF) has been implicated in the pathogenesis of coronary artery disease (CHD). We explored the plasma MIF level and studied its predictive value of major adverse cardiac events in CHD patients. Methods: There were 126 patients with acute myocardial infaction (AMI), 154 patients with unstable angina (UA), 40 patients with stable angina (SA) who were recruited from First Affiliate Hospital of Xi'an Jiaotong University from January 2012 to December 2013. At the same time, 116 control patients with coronary adiography negative and without heart disease history were selected. The next day morning, fasting venous blood were collected. Plasma MIF levels were measured by ELISA. All patients were followed up for a period of around 1 year. The endpoint events were defined as major adverse cardiac events (MACE), including cardiac death, non-fatal myocardial infarction and target vessel revascularization (TVR). Results: The plasma MIF levels were significantly higher in CHD than in control patients (11.12 (6.81, 11.86) vs. 4.42 (3.15, 6 .50) ng/ml. Meanwhile, plasma MIF levels were much higher in AMI than UA (17.51 (13.28, 26.90) vs. 7.80 (5.41, 11.66) ng/ml, P<0.01) and SA patients (17.51 (13.28,26.90) vs. 7.68 (4.60,10.98) ng/ml, P<0.01). During the period of follow up, 17 patients with AMI or UA who had lower MIF level experienced endpoint events. Multivariate logistic regression analysis revealed that the increment of MIF levels (per 10 ng/ml MIF) resulted in a markedly reduced risk for MACE (OR¼0.78, 95% CI 0.61-1.04) in AMI patients. Kaplan-Meier plots for MACE-free survivals showed a significant difference between higher and lower MIF levels in AMI patients (Logrank¼23.751, P<0.01). Corrected by traditional cardiovascular risk factors, circulating MIF in acute stage still played a notable protective effect in AMI patients (HR¼0.78, 95% CI 0.61-1.04). The c-statistic showed that the predictive value of MIF level was incremental over that of the conventional predictors for coronary events in AMI group. Conclusions: Plasma MIF levels are significant higher in CHD group, especially in AMI patients. AMI patients with much higher MIF level in acute stage have fewer MACE events than those patients who have lower MIF level. Acute stage MIF level can be an independent prognostic predictive factor for AMI patients.
Funding: This work was supported by the National Basic Research Program of China ("973 Project" No. 2012CB517804 ).
GW25-e0508
Effects of impaired glucose metabolism on heart rate variability in patients with coronary atherosclerotic heart disease Liu Jinlai, Wu Huilan, Li Suhua, Luo Yanting, Dong Ruimin, Zhu Jieming Department of Cardiology, the Third Affiliated Hospital, Sun Yat-sen University, Tianhe Road, Guangzhou 510630, China
Objectives: The effects of impaired glucose metabolism (IGM) on heart rate variability (HRV) in patients with coronary atherosclerotic heart disease have been less studied. The study aimed to compare the heart rate, HRV and the circadian variation of heart rate among the patients with combined coronary atherosclerotic heart disease and impaired glucose metabolism, the patients with coronary atherosclerotic heart disease, and the normal control; to investigate the relation between different levels of HbA1c and the parameters of HRV in coronary atherosclerotic heart disease patients with IGM. Methods: The study population consisted of three groups: 129 patients with combined angiographically documented coronary atherosclerotic heart disease and IGM (Group CAD + IGM), 207 patients with angiographically documented coronary atherosclerotic heart disease (Group CAD), and 76 normal subjects (Group Control). We divided the group CAD + IGM into 2 subgroups according to the levels of HbA1c (Group HbA1c!7.0%, and Group HbA1c<7.0%). All subjects' clinical data, fasting blood results, LVEF, and the features of coronary artery lesions by coronary angiography or coronary 320-slice CT were collected. All subjects performed a 24-hour dynamic electrocardiogram monitoring. The 24-hour means heart rate, time domain and frequency domain parameters of HRV were collected.
Results: There was a significant decline of 24-hour values of all HRV parameters in group CAD + IGM vs group CAD and group Control, with the highest in controls, the intermediate in group CAD, and the lowest value in group CAD + IGM. SDNN, SDANN, SDNN-Index, RMSSD, PNN50 and TP, VLF, LF, HF were significantly different among these three groups (P<0.05). The mean heart rate of group CAD + IGM, group CAD, and group Control showed a trend of gradually reducing. The mean heart rate presented a marked day-night pattern in all three groups, with a decline in nighttime and a increase in daytime. The variation trend among three groups had a significant difference (P<0.05).The 24-hour values of all HRV parameters between the subgroup HbA1c!7.0% and subgroup HbA1c<7.0% did not show significant differences. Conclusions: Patients with coronary atherosclerotic heart disease present a cardiac autonomic nervous dysfunction. Impaired glucose metabolism can make a further exacerbation on the cardiac autonomic nervous dysfunction of these coronary atherosclerotic heart disease patients. The mean heart rate present a marked day-night pattern in all three groups, with a decline in nighttime and a increase in daytime. But the nighttime heart rate in group Control decreases to a significantly lower level than those in the other two groups. The 24-hour values of all HRV parameters between the subgroup HbA1c!7.0% and subgroup HbA1c<7.0% do not show significant differences.
GW25-e1391
Sex differences in risk factors in patients with acute coronary syndrome Qu Yanwu, Ding Yan-Chun Department of Cardiology V, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China
Objectives: To provide a theoretical basis for clinical prevention and treatment of coronary heart disease in patients with different gender by analyzing the gender differences in patients with risk factors of ACS. Methods: The clinical data and angiographic results of 1269 ACS patients were collected from March 2012 to January 2014, including 901 male patients and 368 female patients. The patients were grouped by age into middle-aged group (age 55) and older-aged group (age>55), and grouped by blood lipid levels into normal HDL -C group (!0.91 mmol/L) and HDL -C lower group (< 0.91 mmol/L), while also divided into non-HDL-C<3.37 mmol/L group and non-HDL-C!3.37 mmol/L group. The traditional CHD risk factors (including age, smoking, blood pressure, blood glucose, BMI, family history) and coronary angiographic changes of these patients are analyzed and compared between different genders. Results: (1) The age of female ACS patients is 68.0AE8.5 years old and that of the male patients is 62.3AE11.2 years old, so the women's onset age of acute coronary syndrome (ACS) is older than men's. (2) The incidence of women with hypertension and diabetes is higher than that of men, and the proportion of men with a smoking history is significantly higher than that of women (P<0.05). (3) According to the division standard of Chinese adults' Blood lipid control guide, the TC at the appropriate level accounted for 73.9% of men, which accounted for 60.6% of women. The TG at the appropriate level accounted for 56.9% of men, which accounted for 45.9% of women. The LDL-C at the appropriate level accounted for 65.3% of men, which accounted for 57.6% of women. The HDL-C at the appropriate level accounted for 33.4% of men, which accounted for 55.6% of women. (4). LDL-C/HDL-C of elder women is higher than that of middle-aged women. HDL-C and Apo-a of elder men is higher than that of middle-aged men. (5) The proportion of normal HDL-C both in the middle-aged and elder-aged group of women is higher than that of men, and the proportion of men's lower HDL-C level is higher than that of women's (P<0.05). There is no gender difference in correlation between HDL-C and the severity of coronary artery lesions. (6) In age>55 patients, there have significant gender differences between non-HDL-C<3.37 mmol/L and non-HDL-C!3.37 mmol/L group. But in age 55 patients, there has no difference in correlation between non-HDL-C and the severity coronary artery lesions. Conclusions: (1) The ACS incidence of women in age 55 is lower than that in the same-aged men; however the ACS incidence of women in age>55 significantly increased, even higher than that in the same-aged men. (2) The effect of hypertension and diabetes for women is larger than that for men, while the effect of smoking history for men is larger than that for women. There is no gender difference between CHD
